Squarepoint Ops LLC Tg Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 48,713 shares of TGTX stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,713

Previous 51,711 5.8%

Holding current value

$1.57 Million

Previous $919,000 23.94%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.21 - $25.28 $51,595 - $75,789	-2,998 Reduced 5.8%	48,713 $1.14 Million
Q2 2024 Aug 14, 2024	SELL	$13.32 - $19.19 $127,512 - $183,705	-9,573 Reduced 15.62%	51,711 $919,000
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $3.44 Million - $5.63 Million	-264,540 Reduced 81.19%	61,284 $932,000
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $2.18 Million - $6.13 Million	325,824 New	325,824 $5.57 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $163,209 - $308,550	-15,954 Reduced 19.19%	67,179 $1.01 Million
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $165,355 - $390,449	-33,005 Reduced 28.42%	83,133 $983,000
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $530,750 - $975,559	116,138 New	116,138 $688,000
Q1 2022 May 16, 2022	SELL	$7.81 - $20.45 $103,708 - $271,555	-13,279 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $201,840 - $471,537	13,279 New	13,279 $252,000
Q2 2020 Aug 14, 2020	SELL	$8.9 - $21.84 $654,951 - $1.61 Million	-73,590 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $525,432 - $1.18 Million	73,590 New	73,590 $724,000
Q3 2019 Nov 14, 2019	SELL	$5.38 - $8.99 $192,044 - $320,907	-35,696 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.27 - $8.65 $60,323 - $83,221	9,621 Added 36.9%	35,696 $309,000
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $104,821 - $209,642	26,075 New	26,075 $210,000
Q3 2018 Nov 14, 2018	SELL	$5.15 - $14.0 $73,130 - $198,800	-14,200 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$12.5 - $15.0 $237 - $285	-19 Reduced 0.13%	14,200 $187,000
Q1 2018 May 15, 2018	SELL	$8.7 - $16.8 $32,668 - $63,084	-3,755 Reduced 20.89%	14,219 $202,000
Q4 2017 Feb 14, 2018	BUY	$7.35 - $12.3 $132,108 - $221,080	17,974	17,974 $147,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.69B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Tg Therapeutics, Inc. Transaction History